<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0005">
 <label>Table 1</label>
 <caption>
  <p>The radionuclides most commonly employed in PET imaging, with some of their advantages and disadvantages.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Radionuclide</th>
    <th align="left">
     <italic>T</italic>
     <sub>1/2</sub>
    </th>
    <th align="left">Advantages</th>
    <th align="left">Disadvantages</th>
    <th align="left">Chemistry for radionuclide incorporation</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <sup>15</sup>O
    </td>
    <td align="left">122 s</td>
    <td rowspan="2" align="left">Probe can be labeled without any change in its molecular structure</td>
    <td rowspan="2" align="left">Requires on-site cyclotron.
     <break/>Not feasible for commercialization of probes
    </td>
    <td align="left">Water (H
     <sub>2</sub>
     <sup>15</sup>O) production
    </td>
   </tr>
   <tr>
    <td align="left">
     <sup>13</sup>N
    </td>
    <td align="left">9.9 min</td>
    <td/>
   </tr>
   <tr>
    <td align="left">
     <sup>11</sup>C
    </td>
    <td align="left">20 min</td>
    <td align="left">Substitution of 
     <sup>12</sup>C with 
     <sup>11</sup>C possible so no change in molecular structure
    </td>
    <td align="left">Requires on-site cyclotron.
     <break/>Not feasible for commercialization of probes
    </td>
    <td align="left">Methylation</td>
   </tr>
   <tr>
    <td align="left">
     <sup>68</sup>Ga
    </td>
    <td align="left">68.3 min</td>
    <td align="left">Generator commercially available, affordable</td>
    <td align="left">Addition of chelate structure usually requires large molecule</td>
    <td align="left">Metal chelation</td>
   </tr>
   <tr>
    <td align="left">
     <sup>18</sup>F
    </td>
    <td align="left">110 min</td>
    <td align="left">Direct labeling of probe; excellent spatial resolution. Low energy (0.635 MeV; 97% β
     <sup>+</sup>). Available and affordable
    </td>
    <td align="left">May not be appropriate for labeling large molecules with slow pharmacokinetics, due to short half-life</td>
    <td align="left">Nucleophilic or electrophilic substitution</td>
   </tr>
   <tr>
    <td align="left">
     <sup>64</sup>Cu
    </td>
    <td align="left">12.7 h</td>
    <td align="left">Useful for probes with slow pharmacokinetics</td>
    <td align="left">Limited commercial availability and expensive</td>
    <td align="left">Metal chelation</td>
   </tr>
   <tr>
    <td align="left">
     <sup>76</sup>Br
    </td>
    <td align="left">16.2 h</td>
    <td align="left">Direct labeling of probe</td>
    <td align="left">Limited commercial availability and expensive</td>
    <td align="left">Halide addition or substitution</td>
   </tr>
   <tr>
    <td align="left">
     <sup>89</sup>Zr
    </td>
    <td align="left">78.4 h</td>
    <td align="left">Relatively inexpensive</td>
    <td align="left">Loss of spatial resolution due to high energy (0.901 MeV; 22.8% β
     <sup>+</sup>)
    </td>
    <td align="left">Metal chelation</td>
   </tr>
   <tr>
    <td align="left">
     <sup>124</sup>I
    </td>
    <td align="left">100.3 h</td>
    <td align="left">Direct labeling of probe; commercially available</td>
    <td align="left">Loss of some spatial resolution due to high energy (2.1 MeV; 24% β
     <sup>+</sup>)
    </td>
    <td align="left">Halide addition or substitution</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
